202 related articles for article (PubMed ID: 19814731)
1. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.
Navarro-Núñez L; Rivera J; Guerrero JA; Martínez C; Vicente V; Lozano ML
Br J Pharmacol; 2009 Nov; 158(6):1548-56. PubMed ID: 19814731
[TBL] [Abstract][Full Text] [Related]
2. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids.
Wright B; Moraes LA; Kemp CF; Mullen W; Crozier A; Lovegrove JA; Gibbins JM
Br J Pharmacol; 2010 Mar; 159(6):1312-25. PubMed ID: 20148891
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor.
Guerrero JA; Lozano ML; Castillo J; Benavente-García O; Vicente V; Rivera J
J Thromb Haemost; 2005 Feb; 3(2):369-76. PubMed ID: 15670046
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.
Guerrero JA; Navarro-Nuñez L; Lozano ML; Martínez C; Vicente V; Gibbins JM; Rivera J
Br J Clin Pharmacol; 2007 Aug; 64(2):133-44. PubMed ID: 17425630
[TBL] [Abstract][Full Text] [Related]
5. Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements.
Del Turco S; Sartini S; Cigni G; Sentieri C; Sbrana S; Battaglia D; Papa A; Da Settimo F; La Motta C; Basta G
Food Chem; 2015 May; 175():494-9. PubMed ID: 25577111
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet Effects of Flavonoid Aglycones Are Mediated by Activation of Cyclic Nucleotide-Dependent Protein Kinases.
Balykina A; Naida L; Kirkgöz K; Nikolaev VO; Fock E; Belyakov M; Whaley A; Whaley A; Shpakova V; Rukoyatkina N; Gambaryan S
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732081
[TBL] [Abstract][Full Text] [Related]
7. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
8. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway.
Navarro-Núñez L; Lozano ML; Palomo M; Martínez C; Vicente V; Castillo J; Benavente-García O; Diaz-Ricart M; Escolar G; Rivera J
J Agric Food Chem; 2008 May; 56(9):2970-6. PubMed ID: 18410117
[TBL] [Abstract][Full Text] [Related]
9. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.
Quinton TM; Kim S; Derian CK; Jin J; Kunapuli SP
J Biol Chem; 2004 Apr; 279(18):18434-9. PubMed ID: 14973136
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.
De Candia E; De Cristofaro R; Landolfi R
Circulation; 1999 Jun; 99(25):3308-14. PubMed ID: 10385507
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
12. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
13. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.
Suidan HS; Clemetson KJ; Brown-Luedi M; Niclou SP; Clemetson JM; Tschopp J; Monard D
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):939-45. PubMed ID: 8645180
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action.
Nylander S; Mattsson C
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):159-67. PubMed ID: 12632026
[TBL] [Abstract][Full Text] [Related]
15. PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets.
Henriksen RA; Hanks VK
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):861-6. PubMed ID: 12006403
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of proteinase-activated receptor agonists on human platelets.
Chung AW; Jurasz P; Hollenberg MD; Radomski MW
Br J Pharmacol; 2002 Mar; 135(5):1123-32. PubMed ID: 11877318
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4-Mediated Thrombin Resistance.
Gnanenthiran SR; Pennings GJ; Reddel CJ; Campbell H; Kockx M; Hamilton JR; Chen VM; Kritharides L
Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):960-972. PubMed ID: 35708029
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H
FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739
[TBL] [Abstract][Full Text] [Related]
19. Iron levels found in hemochromatosis patients inhibit γ-thrombin-induced platelet aggregation.
Lynch S; Soslau G
Platelets; 2012; 23(8):611-6. PubMed ID: 22111666
[TBL] [Abstract][Full Text] [Related]
20. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
